Delivery Order SPE2DB20D2104-SPE2DB22FR32W
Award Date 12/21/21
Potential Completion Date 12/22/21
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,346.28, is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 10, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,652.47, is for the delivery of Microgestin FE 1.5-30 tablets (28s). The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,674.45 firm-fixed-price delivery order is for the pharmaceutical product MICROGESTIN FE 1.5-30 TAB 28S. There was no set-aside used for this award. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,557.38 firm fixed price delivery order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a prescription medication. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,009.19 Firm Fixed Price Delivery Order contract covers the provision of MICROGESTIN FE 1.5-30 TAB 28S, a type of prescription medication, with a period of performance through February 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,489.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554834923 - MICROGESTIN FE 1-20 TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of September 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for a...
- This federal contract award, valued at $4,592.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product, with a completion date of February 22, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award is for the delivery of Microgestin FE 1.5-30 Tab 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $1,770.95 and a completion date of July 12, 2022. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB23FT28T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,325.94 firm fixed-price delivery order is for the supply of MICROGESTIN FE 1-20 TABLET 28S, with a completion date of May 1, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,887.44 firm fixed-price delivery order is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The award is not associated with a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle...